Original fundamental research starts and ENDS here.
Sectors Tags Blog
VRTX
3 filings
Timeline Columns Start Research 8-K Categories
Showing: M&A Clear filter
2024
Q2 3 filings
Jun
Alpine Acquisition Accounting Impact
$4.4B AIPR&D expense from $5B Alpine acquisition
8-K
May
Acquired Alpine Immune Sciences
$5.0B equity value deal completed
8-K
Apr
Acquired Alpine Immune Sciences
$65/share cash tender offer
8-K
SECENDS is not affiliated with the SEC. Data from public EDGAR filings. Not financial advice.